Monkeypox infection in pregnancy: a systematic review and metaanalysis
- PMID: 36096413
- PMCID: PMC9555294
- DOI: 10.1016/j.ajogmf.2022.100747
Monkeypox infection in pregnancy: a systematic review and metaanalysis
Abstract
Objective: The World Health Organization has recently declared a monkeypox outbreak as a public health emergency of global concern. The main aim of this systematic review was to ascertain the maternal and perinatal outcomes of pregnancies complicated by monkeypox infection.
Data sources: The Medline, Embase, and Cochrane databases were searched on June 25, 2022 utilizing combinations of the relevant medical subject heading terms, key words, and word variants for "monkeypox" and "pregnancy."
Study eligibility criteria: The search and selection criteria were restricted to the English language.
Methods: The outcomes observed were miscarriage; intrauterine, neonatal, and perinatal death; preterm birth, vertical transmission, and maternal symptoms. A metaanalysis of proportions was used to analyze the data.
Results: Four studies were included. All the cases in the present systematic review presented with symptoms and signs of monkeypox infection. There was no case of maternal death. Miscarriage occurred in 39% of cases (95% confidence interval, 0-89.0), whereas intrauterine fetal death occurred in 23.0% (95% confidence interval, 0-74.0) of cases. The overall incidence of late fetal and perinatal loss was 77.0% (95% confidence interval, 26.0-100), whereas only 23% (95% confidence interval, 0-74.0) of the included fetuses survived to birth. The incidence of preterm birth before 37 weeks of gestation was 8.0% (95% confidence interval, 0-62.0). Vertical transmission occurred in 62.0% (95% confidence interval, 3.0-100) of cases. When stratifying the analysis according to gestational age at infection, fetal loss was found to occur in 67.0% (95% confidence interval, 9.0-99.0) of cases with first-trimester infection and in 82.0% (95% confidence interval, 17.0-100) of those with second-trimester infection.
Conclusion: Monkeypox infection in pregnancy is associated with a high risk of perinatal loss and vertical transmission. The preliminary results from this systematic review affected by a very small number of included cases highlight the need for thorough maternal and fetal surveillance in pregnancies complicated by monkeypox infection.
Keywords: monkey pox; outcome; pregnancy.
Copyright © 2022 Elsevier Inc. All rights reserved.
Comment in
-
Monkeypox virus in pregnancy, do we have sufficient evidence?Am J Obstet Gynecol MFM. 2023 Mar;5(3):100806. doi: 10.1016/j.ajogmf.2022.100806. Epub 2022 Nov 10. Am J Obstet Gynecol MFM. 2023. PMID: 36371033 Free PMC article. No abstract available.
-
Reply to the Letter to Editor 'Monkeypox virus in pregnancy, do we have sufficient evidence?'.Am J Obstet Gynecol MFM. 2023 Mar;5(3):100807. doi: 10.1016/j.ajogmf.2022.100807. Epub 2022 Nov 10. Am J Obstet Gynecol MFM. 2023. PMID: 36371034 Free PMC article. No abstract available.
References
-
- Henderson LK, Craig JC, Willis NS, Tovey D, Webster AC. How to write a Cochrane systematic review. Nephrology (Carlton) 2010;15:617–624. - PubMed
-
- NHS Centre for Reviews and Dissemination . 2009. Systematic reviews: CRD's guidance for undertaking reviews in health care.https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf Available at: Accessed December 3, 2016.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical